Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
New Playmates on the Presenilin/γ-Secretase Playground
8 July 2002. Two proteins-the recently described aph-1 gene product (see Goutte, et al. ) as well as a novel protein-likely play a role in the production of amyloid-beta (Aβ) via the presenilin/γ-secretase pathway, according to a study in the July of issue of Developmental Cell.

Sometimes overlooked in the brouhaha over whether presenilin is the γ-secretase is the fact that there are other, anonymous proteins hovering around the pathway that generates Aβ from the amyloid precursor protein (AβPP). There is clear evidence that presenilin and γ-secretase cofractionate with other proteins, and only one of these-nicastrin or APH-2-has been positively identified as being critical for AβPP processing. However, recent work in the Notch signaling cascade, which is critical throughout ontogeny and which seems dependent on the same γ-secretase, has pointed out another accessory, termed APH-1, as necessary for γ-secretase activity.

In the current study, Daniel Curtis, Ross Francis, and colleagues at Exelixis, Inc., in South San Francisco and at Pharmacia’s Discovery Research in Kalamazoo, Michigan, screened the genome of mutagenized C. elegans worms and found that aph-1 and a novel gene termed presenilin enhancer 2 (pen-2) interact with presenilin. The aph-1 gene encodes a protein predicted to consist of 308 amino acids, with seven transmembrane segments, whereas pen-2 is predicted to encode a protein of 101 amino acids, with two transmembrane segments.

Both of these C. elegans genes were found to have human homologues, two of which were mapped to loci implicated in Alzheimer’s disease on chromosomes 1 and 19. When they looked in human tissues, the researchers found that the human aph-1 and pen-2 homologues were broadly expressed, including in brain. Localization experiments in C. elegans, successful for pen-2 only, found the gene product in intracellular membrane compartments.

Further experiments in C. elegans mutants showed that the aph-1 and pen-2 genes are not only critical to proper Notch pathway functioning, but they specifically interact with the presenilin and aph-2/nicastrin genes. In the Notch pathway, aph-1 and pen-2 were shown to act at, or upstream of, the S3 cleavage step that appears to be the γ-secretase step.

Switching to cultured Drosophila cells, the researchers showed that inactivation of either aph-1, pen-1, or aph-2/nicastrin reduces γ-secretase cleavage of AβPP, reduces processing of presenilin, and lowers the production of Aβ-40 and -42.

“If APH-1 and PEN-2 proteins interact directly with each other and with presenilin, these interactions could be transitory during early steps in γ-secretase complex assembly or may persist in the mature enzyme complex,” note the authors.-Hakon Heimer.

Reference:
Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, Nicoll M, Maxwell M, Hai B, Ellis MC, Parks AL, Xu W, Li J, Gurney M, Myers RL, Himes CS, Hiebsch R, Ruble C, Nye JS, Curtis D. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of beta-APP, and presenilin protein accumulation. Develop Cell. Jul 2002;3(1):85-97. Abstract

 
Comments on News and Primary Papers
  Primary Papers: aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation.

Comment by:  John Portovski
Submitted 4 March 2006  |  Permalink Posted 5 March 2006
  I recommend this paper

Great page, not too fancy but well balanced! Cheers!

References:
Google

View all comments by John Portovski
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad